Skip to main content

Blog

Update on the FDA’s Review of Deramiocel: Continuing the Path Forward

...

Thank You for Raising Your Voices During the Deramiocel FDA Advisory Committee Meeting

...

Ahead of the July 29 Advisory Committee: We Urge the FDA to Consider the Totality of Evidence

...

What to Know Ahead of This Week’s Deramiocel FDA Advisory Committee Meeting

...

PPMD Honored with RAPS 2026 Patient-Centered Health Award

...

FDA Accepts Dyne Therapeutics’ Biologics License Application for Z-Rostudirsen

...

Highlights from PPMD’s 2026 Annual Conference

...

Preparing for the Deramiocel FDA Advisory Committee Meeting: How to Submit Written Testimony

...

FDA Accepts sNDAs to Review Traditional Approval for AMONDYS 45 and VYONDYS 53

...

Catching Up on PPMD’s 2026 Annual Conference: Part II

...